Advance Search
YANG Hanping, LIU Bing, ZHANG Huiying, WANG Lin, LIU Guohua. Application value of leptin combined with adiponectin in differential diagnosis of colorectal cancer and colorectal adenoma[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 85-89. DOI: 10.7619/jcmp.20221353
Citation: YANG Hanping, LIU Bing, ZHANG Huiying, WANG Lin, LIU Guohua. Application value of leptin combined with adiponectin in differential diagnosis of colorectal cancer and colorectal adenoma[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 85-89. DOI: 10.7619/jcmp.20221353
shu

Application value of leptin combined with adiponectin in differential diagnosis of colorectal cancer and colorectal adenoma

  • Department of General Surgery, Handan City First Hospital of Hebei Province, Handan, Hebei, 056000

More Information
  • Received Date: April 24, 2022
  • Available Online: November 17, 2022
    Graphical Abstract
    • Abstract
  • Objective 

    To explore the value of leptin and adiponectin in the differential diagnosis of colorectal cancer and colorectal adenoma.

    Methods 

    A total of 140 patients with colorectal cancer were selected as colorectal cancer group, and 168 patients with colorectal adenoma were selected as colorectal adenoma group. Another 170 healthy people were selected as control group. Serum leptin and adiponectin were detected by enzyme-linked immunosorbent assay (ELISA). Pearson correlation analysis was used to analyze the relationship between serum leptin and adiponectin in patients with colorectal cancer and patients with colorectal adenoma. Logistic regression model was used to analyze the independent risk factors of colorectal cancer. Values of serum leptin, adiponectin and their combination in the differential diagnosis of colorectal cancer and colorectal adenoma were analyzed by receiver operating characteristic (ROC) curve.

    Results 

    The serum leptin levels in the control group, the colorectal adenoma group and the colorectal cancer group were (1.52±0.46), (2.31±0.75) and (4.56±1.36) ng/mL respectively, which showed a gradual and significant increasing trend (P < 0.05); the serum adiponectin levels in the control group, the colorectal adenoma group and the colorectal cancer group were (18.83±5.24), (15.36±4.11) and (11.28±3.16) μg/mL respectively, which showed a gradual and significant decreasing trend (P < 0.05). Pearson correlation analysis showed that there was a negative correlation between serum leptin and adiponectin in colorectal adenoma patients and colorectal cancer patients (r=-0.493, -0.537, P < 0.001). Logistic regression analysis showed that high level of leptin and low level of adiponectin were the independent risk factors for colorectal cancer (P < 0.05). ROC curve showed that the area under the curve (AUC) of leptin combined with adiponectin in the differential diagnosis of colorectal cancer and colorectal adenoma was 0.905, the sensitivity was 90.00%, and the specificity was 82.70%.

    Conclusion 

    There are differences in the serum levels of leptin and adiponectin in patients with colorectal cancer and patients with colorectal adenoma, and the detections of leptin, adiponectin and their combination show certain clinical value in colorectal cancer screening.

    • FullText(HTML)
    • References (17)
  • [1]
    陶丹, 郭莲怡. NLR、PLR、MPV预测结直肠腺瘤性息肉和结直肠癌的临床意义[J]. 胃肠病学, 2020, 25(3): 162-166. doi: 10.3969/j.issn.1008-7125.2020.03.006
    [2]
    李祎龙, 雷凯, 张小昭, 等. 1, 25-二羟维生素D3对人结肠癌细胞凋亡和自噬的影响及机制研究[J]. 实用临床医药杂志, 2021, 25(13): 5-9. doi: 10.7619/jcmp.20211388
    [3]
    MARONI P. Leptin, adiponectin, and Sam68 in bone metastasis from breast cancer[J]. Int J Mol Sci, 2020, 21(3): E1051. doi: 10.3390/ijms21031051
    [4]
    CREAN-TATE K K, REIZES O. Leptin regulation of cancer stem cells in breast and gynecologic cancer[J]. Endocrinology, 2018, 159(8): 3069-3080. doi: 10.1210/en.2018-00379
    [5]
    CHAKRABORTY D, JIN W, WANG J. The bifurcated role of adiponectin in colorectal cancer[J]. Life Sci, 2021, 278: 119524. doi: 10.1016/j.lfs.2021.119524
    [6]
    姚宏伟, 刘荫华. NCCN结直肠癌临床实践指南2011年更新解读[J]. 中华胃肠外科杂志, 2011(4): 234-238. doi: 10.3760/cma.j.issn.1671-0274.2011.04.002
    [7]
    ASHKTORAB H, SOLEIMANI A, NICHOLS A, et al. Adiponectin, leptin, IGF-1, and tumor necrosis factor alpha as potential serum biomarkers for non-invasive diagnosis of colorectal adenoma in African Americans[J]. Front Endocrinol (Lausanne), 2018, 9: 77. doi: 10.3389/fendo.2018.00077
    [8]
    UYAR G O, SANLIER N. Association of adipokines and insulin, which have a role in obesity, with colorectal cancer[J]. Eurasian J Med, 2019, 51(2): 191-195.
    [9]
    GHASEMI A, SAEIDI J, AZIMI-NEJAD M, et al. Leptin-induced signaling pathways in cancer cell migration and invasion[J]. Cell Oncol (Dordr), 2019, 42(3): 243-260.
    [10]
    黄曼玲, 陈志涛, 徐丹, 等. 结直肠癌患者血清脂联素与Cyclin D1和NF-κB的相关性研究及临床意义[J]. 临床消化病杂志, 2019, 31(6): 376-379. doi: 10.3870/lcxh.j.issn.1005-541X.2019.06.08
    [11]
    马翠翠, 李杨, 庞向鹏, 等. 胃癌、结直肠癌患者血清瘦素和脂联素变化及相关性分析[J]. 肿瘤代谢与营养电子杂志, 2019, 6(3): 351-356. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLDX201903023.htm
    [12]
    OBI N, JUNG A Y, MAURER T, et al. Association of circulating leptin, adiponectin, and resistin concentrations with long-term breast cancer prognosis in a German patient cohort[J]. Sci Rep, 2021, 11(1): 23526. doi: 10.1038/s41598-021-02958-w
    [13]
    TOJEK K, ANASZEWICZ M, SZUKAY B, et al. Circulating leptin, adiponectin, and tumor necrosis factor-alpha in patients undergoing surgery due to colorectal cancer[J]. Digestion, 2021, 102(2): 246-255. doi: 10.1159/000504507
    [14]
    尹庚申, 郭明明, 余之刚. 脂联素及其受体在肥胖相关的乳腺癌中的作用[J]. 中华乳腺病杂志: 电子版, 2018, 12(4): 246-249. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHRD201804013.htm
    [15]
    朱文华, 陈丽英, 张佳, 等. 基于脂联素及脂联素受体的代谢综合征干预通路的研究进展[J]. 全科医学临床与教育, 2020, 18(12): 1110-1113. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYL202012016.htm
    [16]
    BURTON A J, GILBERT R, TILLING K, et al. Circulating adiponectin and leptin and risk of overall and aggressive prostate cancer: a systematic review and meta-analysis[J]. Sci Rep, 2021, 11(1): 320. doi: 10.1038/s41598-020-79345-4
    [17]
    PARIDA S, SIDDHARTH S, SHARMA D. Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease[J]. Int J Mol Sci, 2019, 20(10): 2519. doi: 10.3390/ijms20102519
    • Related Articles

  • Cited by

    Periodical cited type(10)

    1. 杨陆涛，曹青. 自体浓缩生长因子联合牛碱性成纤维细胞生长因子外用凝胶在创面修复中的应用. 中国当代医药. 2024(11): 25-28 .
    2. 李娟，郝然，高丽，赵华，涂秀玲. 速愈乐创面敷料在骨科难愈性创面愈合中的应用. 中国美容医学. 2023(06): 56-59 .
    3. 梁玉祥，郎志刚，郭强，张旭，何冬，李可烨. 富血小板纤维蛋白联合泡沫敷料治疗慢性感染伤口的疗效及抑菌作用分析. 实用临床医药杂志. 2023(21): 69-72 . 本站查看
    4. 宋霞，刘桂荣，方秋娜，何志琴. 新型敷料结合心理护理干预对慢性伤口患者的影响. 心理月刊. 2022(04): 167-169 .
    5. 王静，陈亚萍. 加温涡流式冲洗联合VSD在骨科慢性伤口护理中的应用效果. 临床医学研究与实践. 2022(15): 164-167+187 .
    6. 谢远鸿，郑军，洪劲超，赵晨，彭良超，袁健林. 富自体浓缩生长因子纤维蛋白液联合骨修复材料对上颌前牙区骨缺损引导骨再生的效果. 中国医药科学. 2022(08): 173-175+196 .
    7. 牛晓暐，李建友，李田田，吴珣. AgNP敷料促进深度烧伤致慢性难愈性创面修复的效果及VEGF/MMP-9信号通路机制研究. 临床和实验医学杂志. 2022(11): 1208-1211 .
    8. 葛洪源. 富血小板血浆联合VSD技术治疗慢性难愈性创面的效果分析. 医学理论与实践. 2022(21): 3672-3674 .
    9. 胡娟，叶志英，范李，郝杰，杨帆. 益气活血汤联合负压封闭引流术治疗慢性伤口38例. 中国中医骨伤科杂志. 2021(09): 55-57 .
    10. 陈诺，李羽霖，阮琼芳，谢卫国. 浓缩生长因子及其在促进损伤组织修复中的应用进展. 中华损伤与修复杂志(电子版). 2021(06): 520-524 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (129) PDF downloads (8) Cited by(10)
    Turn off MathJax
    Article Contents
    Abstract
    References

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return